Conspectus
Small molecule imaging probes are powerful tools to understand
complex biological systems. The mainstreams of imaging probe developments
have been focused on the target holding of the probes; the holding
targets are often cell-type-specific biomarkers. This type of the
probe mechanism can be designated as holding-oriented live-cell distinction
(HOLD).
Our group has worked on the development of cell-type-selective
probes using a diversity-oriented fluorescence library approach (DOFLA),
where unbiased phenotypic screening is employed using fluorescent
library compounds. Through the conventional target identification
methods such as an affinity-based analysis, we elucidated that some
of the probe mechanisms are HOLD. However, we also realized that sometimes
there is no specific holding target for probes or the holding targets
are ubiquitous.
The observation led us to test an alternative
mechanism of cell-type-specific
probes as gating-oriented live-cell distinction (GOLD). We started
to examine the gating mechanism of probes, which is mainly based on
transporters but which does not necessarily require probe holding
to cellular targets. Transporters can control the in and out movement
of various nutrients and chemicals. Different expression levels of
transporters in various cell types could provide the molecular mechanism
of differential staining of cells by regulating the intracellular
accumulation of a certain specific probe. A number of GOLD probes
have been developed by modifying or mimicking endogenous substrates
of transporters such as inorganic ions, glucose, amino acids, or neurotransmitters,
utilizing broad substrate specificity of transporters. The radiolabeled
or fluorophore-conjugated substrate mimetics have been widely used
for live cell distinction and various applications such as disease-related
cell or tissue imaging.
In humans, there are about 400 solute
carrier (SLC) transporters
and 50 ATP-binding cassette (ABC) transporters. Since some transporters
have broad substrate specificity, they can transport not only derivatives
of endogenous natural substrates but also totally synthetic diverse
imaging probes, such as DOFLA probes. Without preconsidering the structure
of endogenous substrates, we recently demonstrated a series of live-cell
imaging probes and elucidated their molecular mechanism as a gating
one, either by SLC or ABC transporters. Transporter inhibitor panel
and CRISPR-based transporter libraries could provide a systematic
gating target elucidation platform.
Considering the generality
of DOFLA and the CRISPR-based genomic
tool for transporter systems (>450 in humans), the GOLD approach
will
offer new insight and promise for unprecedented levels of novel cell
imaging probe development.